NEW! - In order to provide the best possible service to the many customers benefitting from taking the Nutrivene-D supplement, abp has set up a dedicated department to handle this important product line. For placing orders or for assistance, please contact Juliette Young at (+44).(0).208.786.8431 or via email at Nutrivene@abplimited.co.uk
Other abp Product Offerings
	(ristocetin sulfate)
	VWF Activity
	VWF Total Antigen
	NuTriVene-D
	Indigo Carmine
	IC-Green
	Pharmaceuticals, etc.

Nutrivene-D Daily Supplement contains over 40 nutrients including vitamins, minerals, and antioxidants Zinc, Selenium, Coenzyme Q10, Alpha Lipoic Acid, Glutathione, Bioflavonoids, Vitamins A, C, and E. (To receive a complete nutrition profile for this product, email us at Nurtivene@abplimited.co.uk or call us at our Epsom, UK office (+44).(0).208.786.8431.)

Some nutrients may aid in the metabolic disturbances in Down syndrome (1,2,3,4,5). These metabolic disturbances are thought to include the disruption of methylation pathways (SAM cycle), connective tissue issues which result in hypotonia, and the overexpression of the superoxide dismutase gene which may cause oxidative stress and accelerated aging.

A study conducted on Nutrivene-D in children with Down syndrome noted a reduction of infections, improved growth, and improvements in laboratory parameters (Vitamins A, E, Selenium, etc.). Parents and therapists involved in the study reported considerable improvements in behavior, cooperation and development of the children administered Nutrivene (6).

The Nutrivene-D Daily Supplement Powder form mixes with infant formulas, baby foods, yogurts, drinks, etc. Nutrivene-D Daily Supplement Powder contains 150 grams.

This supplement, along with the following products, are part of the standard protocol for Down syndrome: (see below) Nutrivene-D Daily Enzyme, Nutrivene-D NightTime Formula, Efalex Gelcaps, Neuromins DHA.

(1) J Neurol 2002 Oct;249(10):1347-56
(2) Am J Hum Genet 2001 Jul;69(1):88-95
(3) Biol Trace Elem Res 2001 Jul;81(1):21-8
(4) Int J Clin Pharmacol Res 2001;21(2)79-84
(5) Mutat Res 1993 Aug;295(3):105-11
(6) Padiat Prax 2001;59:703-708